Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001178913-15-000717

President and CEO acquired 79,848 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2015-02-23 Grant or award +79,848 953,948 D: show line 1 in the form
Loading xslF345X03/zk1516360.xml…